Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome
Status unconfirmed · Phase 4
Conditions studied: Hypertension
In brief
The purpose of the study is to compare the effects of Azor (a combination of amlodipine and olmesartan) with Hyzaar ( a combination of losartan and hydrochlorothiazide) on the thin lining on the inside of blood vessels. These cells help keep blood vessels healthy and blood pressure normal.
Key facts
- Study ID
- NCT01271374
- Run by
- InVasc Therapeutics, Inc.
- People needed
- 80
- Starts
- 2010-04-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2011-05-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- African American
- Hypertension and one of the following:
- Fasting glucose > 100 mg/dl
- HgA1C> 6.0 %
- Plasma triglycerides >150
- HDL cholesterol < 40 mg/dl in men or < 50 mg/dl in women
You may not qualify if…
- History of Heart failure
- use of insulin
- non-dominant arm circ > 50 cm.
Where it is running
- Atlanta Clinical Research Center — Tucker, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.